Markets:

Overview

News

Currencies

International

Treasuries

Adaptive Biotechnologies Corporation - Common Stock (NQ:ADPT)

17.00 +0.50 (+3.03%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Adaptive Biotechnologies Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

What's Going On With Adaptive Biotechnologies (ADPT) Stock? ↗

September 26, 2023

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) shares are trading higher Tuesday despite a lack of company-specific news.

Via Benzinga

Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday ↗

September 26, 2023

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket ↗

September 26, 2023

Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.

Via Benzinga

Adaptive Announces Launch of Epic Integration for clonoSEQ®

September 13, 2023

The Adaptive-Epic integration will provide clinicians and patients with easier access to minimal residual disease (MRD) monitoring in blood cancers

From Adaptive Biotechnologies

Via GlobeNewswire

A Preview Of Adaptive Biotechnologies's Earnings ↗

August 01, 2023

Via Benzinga

Adaptive Biotechnologies's Return On Capital Employed Insights ↗

May 11, 2023

Via Benzinga

Adaptive Biotechnologies to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

August 30, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List ↗

August 28, 2023

Here are some intriguing up-and-coming biotech stocks that may reward risk-tolerant investors with a long-term outlook.

Via InvestorPlace

Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks ↗

August 24, 2023

The Ark Invest CEO continues to trim Shopify holdings to fund some big purchases.

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

August 23, 2023

Via The Motley Fool

Adaptive Biotechnologies: Q1 Earnings Insights ↗

May 03, 2023

Via Benzinga

Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M ↗

August 22, 2023

Via Benzinga

Topics Earnings

Cathie Wood Sells Shopify Shares Worth $9.2M — Ark Goes Shopping This Dutch Payment Company's Stock Instead ↗

August 21, 2023

Via Benzinga

Cathie Wood's Ark Invest Continues To Sell Shopify Shares Amid Q2 Ripples ↗

August 17, 2023

Via Benzinga

Cathie Wood's Ark Invest Sells More Tesla Stock — Acquires Shares Of Flying Taxi Company ↗

August 15, 2023

Via Benzinga

Cathie Wood's Ark Invest Sells $2.15M Of Tesla Shares Despite Own Bullish Projections ↗

August 14, 2023

Via Benzinga

Cathie Wood's Ark Invest Acquires $5.5M of Robinhood Shares Following Platform's First Profitable Quarter ↗

August 03, 2023

Via Benzinga

Adaptive Biotechnologies Reports Second Quarter 2023 Financial Results

August 02, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Trump Advisor Says Ex-President May Skip Initial Republican Presidential Primary Debates ↗

July 11, 2023

Via Benzinga

Cathie Wood's Ark Pours $3.3M More Into This Chipmaker Amid AI Frenzy: Here Are Other Major Monday Trades ↗

July 11, 2023

Via Benzinga

Adaptive Biotechnologies to Report Second Quarter Financial Results on August 2, 2023

July 10, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Why Shares of Adaptive Biotechnologies Jumped This Week ↗

June 16, 2023

The company could see its first FDA-approved therapy as early as next year.

Via The Motley Fool

Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought ↗

June 02, 2023

There are always stocks to buy if you're Ark Invest's ace stock picker.

Via The Motley Fool

Adaptive Biotechnologies Highlights New Data at ASCO 2023 and EHA 2023 Underscoring the clonoSEQ® Assay’s Impact as a Standard for Minimal Residual Disease Assessment in Patients with Hematologic Cancer

June 02, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

May 26, 2023

There are always stocks to buy if you're Ark Invest's ace stock picker.

Via The Motley Fool

Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences

May 24, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

3 Personalized Medicine Stocks to Buy for Long-Time Returns ↗

May 15, 2023

Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out.

Via InvestorPlace

Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare Conference

May 12, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies Announces FDA Acceptance of Genentech’s Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in Oncology

May 09, 2023

The T-Cell Therapy product candidate contains a neoantigen-specific T-cell receptor (TCR) identified and characterized through Adaptive’s TCR discovery platform

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies Reports First Quarter 2023 Financial Results

May 03, 2023

From Adaptive Biotechnologies

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Adaptive Biotechnologies Corporation - Common Stock (NQ:ADPT)

All News about Adaptive Biotechnologies Corporation - Common Stock

Starting at $3.75/week.

Subscribe Today